Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

AutoGenomics, Inc.

Vairavan R.

Pharmacogenomics. 2004 Jul;5(5):585-8.

PMID:
15212595
2.

Microarray technology: an array of opportunities.

Gershon D.

Nature. 2002 Apr 25;416(6883):885-91. No abstract available.

PMID:
11976691
3.

Is this the real time for genomics?

Guarnaccia M, Gentile G, Alessi E, Schneider C, Petralia S, Cavallaro S.

Genomics. 2014 Feb-Mar;103(2-3):177-82. doi: 10.1016/j.ygeno.2014.02.003. Epub 2014 Feb 19. Review.

4.

Affymetrix, Inc.

Yap G.

Pharmacogenomics. 2002 Sep;3(5):709-11.

5.

GENOSENSE Diagnostics GmbH.

Schneeberger C.

Pharmacogenomics. 2004 Jul;5(5):581-3.

PMID:
15212594
6.

DNA microarrays: more than gene expression.

Gershon D.

Nature. 2005 Oct 20;437(7062):1195-8. No abstract available.

PMID:
16237450
7.

Scanning for success.

Jones D.

Nat Rev Drug Discov. 2007 Aug;6(8):590-1. No abstract available.

PMID:
17821827
8.

American College of Medical Genetics and Genomics technical standards and guidelines: microarray analysis for chromosome abnormalities in neoplastic disorders.

Cooley LD, Lebo M, Li MM, Slovak ML, Wolff DJ; Working Group of the American College of Medical Genetics and Genomics (ACMG) Laboratory Quality Assurance Committee.

Genet Med. 2013 Jun;15(6):484-94. doi: 10.1038/gim.2013.49. Epub 2013 Apr 25.

PMID:
23619274
9.

VBC-Genomics Bioscience Research GmbH (LLC).

Schmidt WM.

Pharmacogenomics. 2004 Jun;5(4):439-42.

PMID:
15165180
10.

Functional genomic analysis in pain research using hybridization arrays.

Walker SJ, Worst TJ, Freeman WM, Vrana KE.

Methods Mol Med. 2004;99:239-53.

PMID:
15131342
11.

Company profile: Complete Genomics Inc.

Reid C.

Future Oncol. 2011 Feb;7(2):219-21. doi: 10.2217/fon.10.173.

12.

Will genomics revolutionise pharmaceutical R&D?

Noble D.

Trends Biotechnol. 2003 Aug;21(8):333-7.

PMID:
12902169
13.

DNA microarray technology: devices, systems, and applications.

Heller MJ.

Annu Rev Biomed Eng. 2002;4:129-53. Epub 2002 Mar 22. Review.

PMID:
12117754
14.

CGHScan: finding variable regions using high-density microarray comparative genomic hybridization data.

Anderson BD, Gilson MC, Scott AA, Biehl BS, Glasner JD, Rajashekara G, Splitter GA, Perna NT.

BMC Genomics. 2006 Apr 25;7:91.

15.

Genomic Health, Inc.

Baker J.

Pharmacogenomics. 2007 Apr;8(4):397-9.

16.

An overview of toxicogenomics.

Hamadeh HK, Amin RP, Paules RS, Afshari CA.

Curr Issues Mol Biol. 2002 Apr;4(2):45-56. Review.

17.

Iconix Biosciences, Inc.

Fielden MR, Halbert DN.

Pharmacogenomics. 2007 Apr;8(4):401-5.

PMID:
17391077
18.

Novel genomic methods for drug discovery and mechanism-based toxicological assessment.

Gant TW, Zhang SD, Taylor EL.

Curr Opin Drug Discov Devel. 2009 Jan;12(1):72-80. Review.

PMID:
19152215
19.

Genomic profiling: cDNA arrays and oligoarrays.

Gorreta F, Carbone W, Barzaghi D.

Methods Mol Biol. 2012;823:89-105. doi: 10.1007/978-1-60327-216-2_7. Review.

PMID:
22081341
20.

Integration of genomic technologies for accelerated cancer drug development.

Basik M, Mousses S, Trent J.

Biotechniques. 2003 Sep;35(3):580-2, 584, 586 passim. Review.

PMID:
14513563

Supplemental Content

Support Center